Last reviewed · How we verify
Inactivated SARS-CoV-2 Vaccine (Vero cell)
Inactivated SARS-CoV-2 Vaccine (Vero cell) is a inactivated viral vaccine Biologic drug developed by Sinovac Research and Development Co., Ltd.. It is currently FDA-approved for Prevention of COVID-19 in adults and children. Also known as: CoronaVac.
This inactivated vaccine stimulates the immune system to produce antibodies and cellular immunity against SARS-CoV-2 by presenting whole inactivated viral particles.
This inactivated vaccine stimulates the immune system to produce antibodies and cellular immunity against SARS-CoV-2 by presenting whole inactivated viral particles. Used for Prevention of COVID-19 in adults and children.
At a glance
| Generic name | Inactivated SARS-CoV-2 Vaccine (Vero cell) |
|---|---|
| Also known as | CoronaVac |
| Sponsor | Sinovac Research and Development Co., Ltd. |
| Drug class | inactivated viral vaccine |
| Target | SARS-CoV-2 spike protein and other viral antigens |
| Modality | Biologic |
| Therapeutic area | Immunology / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
The vaccine contains chemically inactivated SARS-CoV-2 virus grown in Vero cells, which cannot replicate but retains viral antigens. When administered, these antigens trigger both humoral (antibody) and cell-mediated immune responses, enabling the body to recognize and neutralize the live virus upon exposure. This approach has been used successfully for decades in other vaccines such as polio and hepatitis A.
Approved indications
- Prevention of COVID-19 in adults and children
Common side effects
- Injection site pain or swelling
- Fatigue
- Headache
- Myalgia
- Fever
- Nausea
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inactivated SARS-CoV-2 Vaccine (Vero cell) CI brief — competitive landscape report
- Inactivated SARS-CoV-2 Vaccine (Vero cell) updates RSS · CI watch RSS
- Sinovac Research and Development Co., Ltd. portfolio CI
Frequently asked questions about Inactivated SARS-CoV-2 Vaccine (Vero cell)
What is Inactivated SARS-CoV-2 Vaccine (Vero cell)?
How does Inactivated SARS-CoV-2 Vaccine (Vero cell) work?
What is Inactivated SARS-CoV-2 Vaccine (Vero cell) used for?
Who makes Inactivated SARS-CoV-2 Vaccine (Vero cell)?
Is Inactivated SARS-CoV-2 Vaccine (Vero cell) also known as anything else?
What drug class is Inactivated SARS-CoV-2 Vaccine (Vero cell) in?
What development phase is Inactivated SARS-CoV-2 Vaccine (Vero cell) in?
What are the side effects of Inactivated SARS-CoV-2 Vaccine (Vero cell)?
What does Inactivated SARS-CoV-2 Vaccine (Vero cell) target?
Related
- Drug class: All inactivated viral vaccine drugs
- Target: All drugs targeting SARS-CoV-2 spike protein and other viral antigens
- Manufacturer: Sinovac Research and Development Co., Ltd. — full pipeline
- Therapeutic area: All drugs in Immunology / Infectious Disease
- Indication: Drugs for Prevention of COVID-19 in adults and children
- Also known as: CoronaVac
- Compare: Inactivated SARS-CoV-2 Vaccine (Vero cell) vs similar drugs
- Pricing: Inactivated SARS-CoV-2 Vaccine (Vero cell) cost, discount & access